vs
EZCORP INC（EZPW）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
EZCORP INC的季度营收约是Orthofix Medical Inc.的1.7倍（$382.0M vs $219.9M），EZCORP INC净利率更高（11.6% vs -1.0%，领先12.6%），EZCORP INC同比增速更快（19.3% vs 2.0%），EZCORP INC自由现金流更多（$31.7M vs $16.8M），过去两年EZCORP INC的营收复合增速更高（15.6% vs 8.0%）
EZCORP是总部位于美国得克萨斯州奥斯汀的典当行运营商，业务覆盖美国及拉丁美洲地区，是美国第二大典当行运营商，仅次于Cash America International，目前在纳斯达克挂牌上市。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EZPW vs OFIX — 直观对比
营收规模更大
EZPW
是对方的1.7倍
$219.9M
营收增速更快
EZPW
高出17.3%
2.0%
净利率更高
EZPW
高出12.6%
-1.0%
自由现金流更多
EZPW
多$14.9M
$16.8M
两年增速更快
EZPW
近两年复合增速
8.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $382.0M | $219.9M |
| 净利润 | $44.3M | $-2.2M |
| 毛利率 | 58.4% | 71.1% |
| 营业利润率 | 15.9% | 0.2% |
| 净利率 | 11.6% | -1.0% |
| 营收同比 | 19.3% | 2.0% |
| 净利润同比 | 42.8% | 92.4% |
| 每股收益（稀释后） | $0.55 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EZPWOFIX
| Q4 25 | $382.0M | $219.9M | ||
| Q3 25 | $336.8M | $205.6M | ||
| Q2 25 | $311.0M | $203.1M | ||
| Q1 25 | $306.3M | $193.6M | ||
| Q4 24 | $320.2M | $215.7M | ||
| Q3 24 | $294.6M | $196.6M | ||
| Q2 24 | $281.4M | $198.6M | ||
| Q1 24 | $285.6M | $188.6M |
净利润EZPWOFIX
| Q4 25 | $44.3M | $-2.2M | ||
| Q3 25 | $26.7M | $-22.8M | ||
| Q2 25 | $26.5M | $-14.1M | ||
| Q1 25 | $25.4M | $-53.1M | ||
| Q4 24 | $31.0M | $-29.1M | ||
| Q3 24 | $15.2M | $-27.4M | ||
| Q2 24 | $17.9M | $-33.4M | ||
| Q1 24 | $21.5M | $-36.0M |
毛利率EZPWOFIX
| Q4 25 | 58.4% | 71.1% | ||
| Q3 25 | 59.0% | 72.2% | ||
| Q2 25 | 59.1% | 68.7% | ||
| Q1 25 | 58.3% | 62.8% | ||
| Q4 24 | 57.9% | 69.0% | ||
| Q3 24 | 59.5% | 68.7% | ||
| Q2 24 | 59.2% | 67.8% | ||
| Q1 24 | 58.7% | 67.5% |
营业利润率EZPWOFIX
| Q4 25 | 15.9% | 0.2% | ||
| Q3 25 | 11.0% | -8.3% | ||
| Q2 25 | 11.6% | -7.9% | ||
| Q1 25 | 11.2% | -25.2% | ||
| Q4 24 | 13.1% | -5.3% | ||
| Q3 24 | 8.8% | -9.6% | ||
| Q2 24 | 7.9% | -12.5% | ||
| Q1 24 | 9.6% | -15.6% |
净利率EZPWOFIX
| Q4 25 | 11.6% | -1.0% | ||
| Q3 25 | 7.9% | -11.1% | ||
| Q2 25 | 8.5% | -6.9% | ||
| Q1 25 | 8.3% | -27.4% | ||
| Q4 24 | 9.7% | -13.5% | ||
| Q3 24 | 5.2% | -13.9% | ||
| Q2 24 | 6.4% | -16.8% | ||
| Q1 24 | 7.5% | -19.1% |
每股收益（稀释后）EZPWOFIX
| Q4 25 | $0.55 | $-0.05 | ||
| Q3 25 | $0.35 | $-0.57 | ||
| Q2 25 | $0.34 | $-0.36 | ||
| Q1 25 | $0.33 | $-1.35 | ||
| Q4 24 | $0.40 | $-0.76 | ||
| Q3 24 | $0.20 | $-0.71 | ||
| Q2 24 | $0.25 | $-0.88 | ||
| Q1 24 | $0.29 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $465.9M | $82.0M |
| 总债务越低越好 | $518.6M | — |
| 股东权益账面价值 | $1.1B | $450.0M |
| 总资产 | $2.0B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资EZPWOFIX
| Q4 25 | $465.9M | $82.0M | ||
| Q3 25 | $469.5M | $62.9M | ||
| Q2 25 | $472.1M | $65.6M | ||
| Q1 25 | $505.2M | $58.0M | ||
| Q4 24 | $174.5M | $83.2M | ||
| Q3 24 | $170.5M | $30.1M | ||
| Q2 24 | $218.0M | $26.4M | ||
| Q1 24 | $229.1M | $27.0M |
总债务EZPWOFIX
| Q4 25 | $518.6M | — | ||
| Q3 25 | $518.1M | $157.2M | ||
| Q2 25 | $517.6M | $157.0M | ||
| Q1 25 | $620.5M | $156.9M | ||
| Q4 24 | $327.7M | $157.0M | ||
| Q3 24 | $327.3M | $118.5M | ||
| Q2 24 | $361.3M | $118.0M | ||
| Q1 24 | $360.9M | $118.2M |
股东权益EZPWOFIX
| Q4 25 | $1.1B | $450.0M | ||
| Q3 25 | $1.0B | $442.5M | ||
| Q2 25 | $990.1M | $458.3M | ||
| Q1 25 | $851.6M | $458.3M | ||
| Q4 24 | $823.9M | $503.1M | ||
| Q3 24 | $804.6M | $525.9M | ||
| Q2 24 | $801.5M | $546.0M | ||
| Q1 24 | $800.4M | $570.3M |
总资产EZPWOFIX
| Q4 25 | $2.0B | $850.6M | ||
| Q3 25 | $2.0B | $832.6M | ||
| Q2 25 | $1.9B | $837.2M | ||
| Q1 25 | $1.8B | $823.1M | ||
| Q4 24 | $1.5B | $893.3M | ||
| Q3 24 | $1.5B | $867.9M | ||
| Q2 24 | $1.5B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比EZPWOFIX
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.51× | 0.36× | ||
| Q2 25 | 0.52× | 0.34× | ||
| Q1 25 | 0.73× | 0.34× | ||
| Q4 24 | 0.40× | 0.31× | ||
| Q3 24 | 0.41× | 0.23× | ||
| Q2 24 | 0.45× | 0.22× | ||
| Q1 24 | 0.45× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $31.7M | $16.8M |
| 自由现金流率自由现金流/营收 | 8.3% | 7.6% |
| 资本支出强度资本支出/营收 | 2.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $121.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流EZPWOFIX
| Q4 25 | $39.1M | $27.7M | ||
| Q3 25 | $51.3M | $12.4M | ||
| Q2 25 | $34.8M | $11.6M | ||
| Q1 25 | $36.9M | $-18.4M | ||
| Q4 24 | $26.0M | $23.7M | ||
| Q3 24 | $43.3M | $11.7M | ||
| Q2 24 | $33.7M | $9.0M | ||
| Q1 24 | $15.1M | $-18.6M |
自由现金流EZPWOFIX
| Q4 25 | $31.7M | $16.8M | ||
| Q3 25 | $35.7M | $2.5M | ||
| Q2 25 | $25.7M | $4.5M | ||
| Q1 25 | $28.6M | $-25.1M | ||
| Q4 24 | $20.4M | $15.2M | ||
| Q3 24 | $24.4M | $6.3M | ||
| Q2 24 | $30.5M | $-360.0K | ||
| Q1 24 | $8.6M | $-29.1M |
自由现金流率EZPWOFIX
| Q4 25 | 8.3% | 7.6% | ||
| Q3 25 | 10.6% | 1.2% | ||
| Q2 25 | 8.3% | 2.2% | ||
| Q1 25 | 9.3% | -13.0% | ||
| Q4 24 | 6.4% | 7.0% | ||
| Q3 24 | 8.3% | 3.2% | ||
| Q2 24 | 10.8% | -0.2% | ||
| Q1 24 | 3.0% | -15.4% |
资本支出强度EZPWOFIX
| Q4 25 | 2.0% | 4.9% | ||
| Q3 25 | 4.6% | 4.8% | ||
| Q2 25 | 2.9% | 3.5% | ||
| Q1 25 | 2.7% | 3.5% | ||
| Q4 24 | 1.8% | 4.0% | ||
| Q3 24 | 6.4% | 2.7% | ||
| Q2 24 | 1.1% | 4.7% | ||
| Q1 24 | 2.3% | 5.6% |
现金转化率EZPWOFIX
| Q4 25 | 0.88× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 2.85× | — | ||
| Q2 24 | 1.88× | — | ||
| Q1 24 | 0.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EZPW
| Merchandise | $210.1M | 55% |
| Pawn Service | $131.9M | 35% |
| Jewelry Scrap | $39.9M | 10% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
